(Fixes typo in paragraph 6) June 5 (Reuters) - The FDA has launched a safety study of the abortion pill, also called ...
Presented by Planned Parenthood{beacon} Health Care Health Care PRESENTED BY The Big Story FDA to review abortion pill safety ...
Ned Sharpless, a first-term Trump health official who has criticized vaccine policies championed by Robert F Kennedy Jr., is ...
By Chris Prentice NEW YORK, June 3 (Reuters) - Acting U.S. FDA Commissioner Kyle Diamantas met with rare disease groups on ...
The effort is expected to take about six months, meaning its results would come after the midterm elections.
The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted a letter of intent for ​an ...
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to ...
June 3 (Reuters) - The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing ...
A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.
Appearance and performance designed to emulate a natural erection ...
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from ...
The FDA is moving ahead with a safety study of the abortion pill mifepristone, a senior FDA official confirmed to CBS News, a ...